Piracetam and levetiracetam, two pyrrolidone derivatives, exert antidystonic activity in a hamster model of paroxysmal dystonia

This publication has 13 references indexed in Scilit:

• Piracetam: Novelty in a Unique Mode of Action
  Pharmacopsychiatry, 1999
• Levetiracetam
  CNS Drugs, 1997
• Effects of piracetam on membrane fluidity in the aged mouse, rat, and human brain
  Biochemical Pharmacology, 1997
• The novel antiepileptic drug levetiracetam (ucb L059) induces alterations in GABA metabolism and turnover in discrete areas of rat brain and reduces neuronal activity in substantia nigra pars reticulata
  Brain Research, 1996
• Effects of levetiracetam, a novel antiepileptic drug, on convulsant activity in two genetic rat models of epilepsy
  Epilepsy Research, 1995
• Profile of ucb L059, a novel anticonvulsant drug, in models of partial and generalized epilepsy in mice and rats
  European Journal of Pharmacology, 1993
• Clinical use of piracetam in epileptic patients
  Current Therapeutic Research, 1992
• Nootropic Drugs Positively Modulate α‐Amino‐3‐Hydroxy‐5‐Methyl‐4‐Isoxazolepropionic Acid‐Sensitive Glutamate Receptors in Neuronal Cultures
  Journal of Neurochemistry, 1992
• Effects of pharmacological manipulation of GABAergic neurotransmission in a new mutant hamster model of paroxysmal dystonia
  European Journal of Pharmacology, 1991
• The Dystonias
  Canadian Journal of Neurological Sciences, 1988